Vaxcyte, Inc. (PCVX) awards 23,029 stock options to director John Markels
Vaxcyte, Inc. (PCVX) director John Markels was granted 23,029 stock options with an exercise price of $56.04 per share. These options will vest over 36 months, with the first third vesting on July 16, 2027, and the remainder vesting monthly thereafter, contingent on his …
PCVX
main company
Sharemaestro market context
Price above Trend Line
52 weeks +79.8%